Proton Pump Inhibitors and Risk of Drug Interactions

Journal Title: Гастроентерологія - Year 2015, Vol 2, Issue 56

Abstract

In the article, the current data regarding drug interactions of proton pomp inhibitors (PPI) with other preparations are discussed. It is concluded that the risk of adverse drug interactions is enhanced by the use of PPIs and drugs primarily metabolized by cytochrome isoenzyme CYP2C19. If the simultaneous application of IPP with many other drugs, including clopidogrel, is necessary, the preference should be given to pantoprazole.

Authors and Affiliations

S. M. Tkach, L. A. Onishchuk

Keywords

Related Articles

On the Problem of Differential Diagnosis of Inflammatory and Functional Bowel Diseases

The paper describes the problems of differential diagnosis of inflammatory (ulcerative colitis, Crohn’s disease) and functional (irritable bowel syndrome) disease of the intestine. The necessity of such differential diag...

Thirty years at the zemstvo work: touches to the portrait of Nadiia Potapivna Kyrpotenko, one of the first female doctors in the Katerynoslav area

In the article, the life path, professional and public activity of Nadiia Potapivna Kyrpotenko — one of the first female doctors in the Katerynoslav area (nowadays the Dnipro area) are presented for the first time. A lot...

Main Indicators of Surgical Care for Patients with Biliary Pathology at the Secondary Level

The authors analyzed the prevalence of cholelithiasis, chronic cholecystitis (CC) and cholangitis, the incidence of this pathology, as well as surgical activity and postoperative mortality due to surgical interventions o...

Clinical Experience of Using Biological Hepatoprotector Prohepar in the Treatment of Patients with Hepatobiliary Pathology (Review)

The article provides an overview of researches to assess the efficacy and safety of using biological hepatoprotector Prohepar in patients with chronic diffuse liver diseases. Used regimens contribute to the normalization...

Modern Methods for Detecting Liver Fibrosis

A liver fibrosis is the basic element in the development of pathological processes in the liver tissue, and fibrosis degree is a specific sensitive enough marker in case of pathological changes in the liver under the inf...

Download PDF file
  • EP ID EP214678
  • DOI -
  • Views 106
  • Downloads 0

How To Cite

S. M. Tkach, L. A. Onishchuk (2015). Proton Pump Inhibitors and Risk of Drug Interactions. Гастроентерологія, 2(56), 93-98. https://europub.co.uk/articles/-A-214678